Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Total Non-Current Liabilities (2018 - 2020)

Historic Total Non-Current Liabilities for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2020 value amounting to $21.9 million.

  • Black Diamond Therapeutics' Total Non-Current Liabilities rose 35058.61% to $21.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $21.9 million, marking a year-over-year increase of 35058.61%. This contributed to the annual value of $21.9 million for FY2020, which is 35058.61% up from last year.
  • Black Diamond Therapeutics' Total Non-Current Liabilities amounted to $21.9 million in Q4 2020, which was up 35058.61% from $19.1 million recorded in Q3 2020.
  • Over the past 5 years, Black Diamond Therapeutics' Total Non-Current Liabilities peaked at $21.9 million during Q4 2020, and registered a low of $2.6 million during Q4 2018.
  • Its 3-year average for Total Non-Current Liabilities is $10.4 million, with a median of $6.9 million in 2020.
  • As far as peak fluctuations go, Black Diamond Therapeutics' Total Non-Current Liabilities surged by 8885.44% in 2019, and later surged by 35058.61% in 2020.
  • Over the past 3 years, Black Diamond Therapeutics' Total Non-Current Liabilities (Quarter) stood at $2.6 million in 2018, then skyrocketed by 88.85% to $4.9 million in 2019, then skyrocketed by 350.59% to $21.9 million in 2020.
  • Its Total Non-Current Liabilities was $21.9 million in Q4 2020, compared to $19.1 million in Q3 2020 and $6.3 million in Q2 2020.